Trial Details
COMPLETEDBasic Information
| Clinical ID | c4364 |
|---|---|
| Identifier | NCT00619489 |
| Trial Title | Long Term Safety of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis|Crohn's Disease |
| Interventions | DRUG: vedolizumab |
Participant Information
| Sponsor | Millennium Pharmaceuticals, Inc. |
|---|---|
| City | Ontario |
| Country/Region | Canada |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2007-12 |
|---|---|
| Primary Completion Date | 2010-03 |
| Completion Date | 2010-03 |